Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 9
1979 33
1980 49
1981 32
1982 49
1983 63
1984 52
1985 64
1986 79
1987 55
1988 58
1989 40
1990 38
1991 51
1992 40
1993 41
1994 55
1995 55
1996 56
1997 57
1998 43
1999 46
2000 46
2001 51
2002 34
2003 44
2004 43
2005 51
2006 58
2007 54
2008 56
2009 60
2010 79
2011 93
2012 76
2013 88
2014 85
2015 91
2016 96
2017 83
2018 86
2019 79
2020 87
2021 56
2022 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

2,372 results

Results by year

Filters applied: . Clear all
Page 1
Tissue-targeted complement therapeutics.
Tomlinson S, Thurman JM. Tomlinson S, et al. Mol Immunol. 2018 Oct;102:120-128. doi: 10.1016/j.molimm.2018.06.005. Epub 2018 Jul 7. Mol Immunol. 2018. PMID: 30220307 Free PMC article. Review.
Editorial: Complement and Immunotherapeutics.
Okrój M, Volokhina E. Okrój M, et al. Front Immunol. 2021 Feb 24;12:663459. doi: 10.3389/fimmu.2021.663459. eCollection 2021. Front Immunol. 2021. PMID: 33717205 Free PMC article. No abstract available.
Material properties in complement activation.
Moghimi SM, Andersen AJ, Ahmadvand D, Wibroe PP, Andresen TL, Hunter AC. Moghimi SM, et al. Adv Drug Deliv Rev. 2011 Sep 16;63(12):1000-7. doi: 10.1016/j.addr.2011.06.002. Epub 2011 Jun 12. Adv Drug Deliv Rev. 2011. PMID: 21689701 Review.
Complement Therapeutics in Autoimmune Disease.
Thurman JM, Yapa R. Thurman JM, et al. Front Immunol. 2019 Apr 3;10:672. doi: 10.3389/fimmu.2019.00672. eCollection 2019. Front Immunol. 2019. PMID: 31001274 Free PMC article. Review.
Editorial: The Role of Complement in Tumors.
Rolfe BE, Pio R, Woodruff TM, Markiewski MM, Manthey HD. Rolfe BE, et al. Front Immunol. 2020 Feb 11;11:139. doi: 10.3389/fimmu.2020.00139. eCollection 2020. Front Immunol. 2020. PMID: 32117286 Free PMC article. No abstract available.
Complement System: a Neglected Pathway in Immunotherapy.
Bordron A, Bagacean C, Tempescul A, Berthou C, Bettacchioli E, Hillion S, Renaudineau Y. Bordron A, et al. Clin Rev Allergy Immunol. 2020 Apr;58(2):155-171. doi: 10.1007/s12016-019-08741-0. Clin Rev Allergy Immunol. 2020. PMID: 31144209 Review.
Advances in assay of complement function and activation.
Harboe M, Thorgersen EB, Mollnes TE. Harboe M, et al. Adv Drug Deliv Rev. 2011 Sep 16;63(12):976-87. doi: 10.1016/j.addr.2011.05.010. Epub 2011 Jun 2. Adv Drug Deliv Rev. 2011. PMID: 21664392 Review.
2,372 results